Loading…

Digital Storytelling Interventions for Cardiovascular Disease Risk Factor Modification: A Scoping Review

Aims: This scoping review intends to map out mechanisms of change, context, and outcomes of studies in which digital storytelling had been used to attempt a modification of harmful health behavior amongst populations with cardiovascular disease risk factors, as well as to identify existing gaps in t...

Full description

Saved in:
Bibliographic Details
Published in:International journal of health, wellness & society wellness & society, 2021, Vol.11 (1), p.209-224
Main Authors: Akinosun, Adewale Samuel, Grant, Noreen, Polson, Rob, Coyle, David, Leslie, Stephen J., Grindle, Mark
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aims: This scoping review intends to map out mechanisms of change, context, and outcomes of studies in which digital storytelling had been used to attempt a modification of harmful health behavior amongst populations with cardiovascular disease risk factors, as well as to identify existing gaps in the research. It also compares findings against the Digital Storytelling Transformative Framework (DSTF) for behavior change. Methods: A database search, qualitative content charting, and data mapping were conducted on relevant publications using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR) reporting guidelines. Results: Digital storytelling has been identified with various health intervention indices, but unlike digital technologies, it does not have a sufficient number of counts across risk factors that would allow it to serve as a basis for clinical evidence in cardiovascular disease-related behavioral risk factor modification. Conclusions: Digital storytelling shows potential and sufficient mapping indices (theories, models, behavior change constructs, processes, mechanisms, and outcomes) as a means of clinical intervention and is therefore ready to be further tested in clinical trials across risk factors to increase its evidence base.
ISSN:2156-8960
2156-9053
DOI:10.18848/2156-8960/CGP/v11i01/209-224